Approaches to handling missing or “problematic” pharmacology data: Pharmacokinetics-Reference-Cited by-同舟云学术

Approaches to handling missing or “problematic” pharmacology data: Pharmacokinetics

Published:2021-04 Issue:4 Volume:10 Page:291-308
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Irby Donald J.¹,Ibrahim Mustafa E.²,Dauki Anees M.¹,Badawi Mohamed A.¹,Illamola Sílvia M.³,Chen Mingqing¹,Wang Yuhuan⁴,Liu Xiaoxi⁴,Phelps Mitch A.¹,Mould Diane R.¹⁵

Affiliation:

1. Division of Pharmaceutics and Pharmacology College of Pharmacy The Ohio State University Columbus OH USA

2. Department of Pharmaceutical Sciences Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Aurora CO USA

3. Department of Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota Minneapolis MN USA

4. Division of Clinical Pharmacology Department of Pediatrics University of Utah School of Medicine Salt Lake City UT USA

5. Projections Research Inc Phoenixville PA USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12611

Reference43 articles.

1. Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective

2. Data Quality Management in Clinical Research.https://oir.nih.gov/sites/default/files/uploads/sourcebook/documents/ethical_conduct/data_quality_management‐2015_05_15.pdf. Accessed April 2 2021.

3. The Simcyp®Population-based ADME Simulator

4. The influence of assay variability on pharmacokinetic parameter estimation

5. Guideline on bioanalytical method validation. In: Agency EM ed.;2012:1–23.https://www.ema.europa.eu/en/documents/scientific‐guideline/guideline‐bioanalytical‐method‐validation_en.pdf. Accessed April 2 2021.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape;Drugs;2024-09-06

2. Identifying optimal dosing strategies for meropenem in the paediatric intensive care unit through modelling and simulation;Journal of Antimicrobial Chemotherapy;2024-08-02

3. Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo;European Journal of Clinical Pharmacology;2024-07-04

4. Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data;Pharmaceutics;2024-06-30

5. Optimization of Vancomycin Initial Dosing Regimen in Neonates Using an Externally Evaluated Population Pharmacokinetic Model;Therapeutic Drug Monitoring;2024-06-06